Innate immunity and neurodegenerative disorders / / topic editors, Roger A. Barker and Francesca Cicchetti.

Inflammation of the brain in the context of neurodegenerative disorders is an area of intense debate and discussion, not least in terms of its pathogenic significance and the extent to which it drives disease processes and pathology. This inflammation can take several forms including innate response...

Full description

Saved in:
Bibliographic Details
:
TeilnehmendeR:
Place / Publishing House:[Lausanne, Switzerland] : : Frontiers Media SA,, 2014.
Year of Publication:2014
Language:English
Series:Frontiers Research Topics
Physical Description:1 online resource (87 pages) :; illustrations; digital, PDF file(s).
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993547286904498
ctrlnum (CKB)3710000000586922
(WaSeSS)IndRDA00059024
(oapen)https://directory.doabooks.org/handle/20.500.12854/50269
(EXLCZ)993710000000586922
collection bib_alma
record_format marc
spelling Francesca Cicchetti auth
Innate immunity and neurodegenerative disorders / topic editors, Roger A. Barker and Francesca Cicchetti.
Frontiers Media SA 2014
[Lausanne, Switzerland] : Frontiers Media SA, 2014.
1 online resource (87 pages) : illustrations; digital, PDF file(s).
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
text file rda
Frontiers Research Topics
Includes bibliographical references.
Inflammation of the brain in the context of neurodegenerative disorders is an area of intense debate and discussion, not least in terms of its pathogenic significance and the extent to which it drives disease processes and pathology. This inflammation can take several forms including innate responses involving microglia, humoral responses involving antibody, complement mediated processes and cellular T-cell activation, of which the role and extent of each may differ between diseases. Whilst some diseases have been more intensely linked to inflammation and long-term degeneration (e.g. MS), more traditional chronic neurodegenerative disorders have been thought of in terms of intrinsic neuronal pathology with a secondary innate response. However, it has been described that microglia activation is an early event of many degenerative disorders and evidence is accumulating that it may play a critical role in actually causing pathology and driving disease processes. If true, this would have major therapeutic implications, but what is the evidence that this is the case?The initial observations by Patrick McGeer’s group of post-mortem tissue from patients with Parkinson’s disease revealed the presence of activated brain microglia long-term and has thus lead to the hypothesis that chronic inflammation could participate to neuronal degenerative processes. The significance of these original observations has only been recently revisited, and the development of more powerful tools to study the brain immune response has certainly contributed to this field of research. Chronic inflammation in the brain can take many forms but of particular interest has been the resident microglia and the role they play in this process. In this context, microglia have often been thought to become activated only after the disease has begun and then to contribute minimally to the degenerative process. Emerging new concepts challenge this view by proposing that microglial senescence, for example, may release the disease process and/or accelerate it. In addition, microglia, once activated, can adopt different phenotypes which can be both pro-inflammatory and pro-repair and may impact not only on the healthy adult neuronal population but on those new neurons derived from neurogenic niches of the adult brain.In this Research Topic, we attempt to explore this by first considering the innate immune responses in the brain and the methods by which they can be studied experimentally and in patients with various neurodegenerative disorders. This sets the scene for then discussing a range of different disorders including Alzheimer’s, Parkinson’s, Huntington’s disease and amyotrophic lateral sclerosis. These papers seek to discuss the evidence for an innate immune response and whether this is beneficial or detrimental, as well as its therapeutic implications.
Description based on: online resource; title from pdf title page (frontiers, viewed Jul. 13, 2016).
English
Natural immunity.
Nervous system Degeneration.
Elelctronic books.
Therapeutics
Inflammation
Immunity
Neurodegenerative disorders
Animal Models
Barker, Roger A., 1961- editor.
Cicchetti, Francesca, editor.
language English
format eBook
author Francesca Cicchetti
spellingShingle Francesca Cicchetti
Innate immunity and neurodegenerative disorders /
Frontiers Research Topics
author_facet Francesca Cicchetti
Barker, Roger A., 1961-
Cicchetti, Francesca,
author_variant f c fc
author2 Barker, Roger A., 1961-
Cicchetti, Francesca,
author2_variant r a b ra rab
f c fc
author2_role TeilnehmendeR
TeilnehmendeR
author_sort Francesca Cicchetti
title Innate immunity and neurodegenerative disorders /
title_full Innate immunity and neurodegenerative disorders / topic editors, Roger A. Barker and Francesca Cicchetti.
title_fullStr Innate immunity and neurodegenerative disorders / topic editors, Roger A. Barker and Francesca Cicchetti.
title_full_unstemmed Innate immunity and neurodegenerative disorders / topic editors, Roger A. Barker and Francesca Cicchetti.
title_auth Innate immunity and neurodegenerative disorders /
title_new Innate immunity and neurodegenerative disorders /
title_sort innate immunity and neurodegenerative disorders /
series Frontiers Research Topics
series2 Frontiers Research Topics
publisher Frontiers Media SA
Frontiers Media SA,
publishDate 2014
physical 1 online resource (87 pages) : illustrations; digital, PDF file(s).
isbn 9782889193103 (ebook)
callnumber-first Q - Science
callnumber-subject QR - Microbiology
callnumber-label QR185
callnumber-sort QR 3185.2
genre Elelctronic books.
illustrated Illustrated
work_keys_str_mv AT francescacicchetti innateimmunityandneurodegenerativedisorders
AT barkerrogera innateimmunityandneurodegenerativedisorders
AT cicchettifrancesca innateimmunityandneurodegenerativedisorders
status_str n
ids_txt_mv (CKB)3710000000586922
(WaSeSS)IndRDA00059024
(oapen)https://directory.doabooks.org/handle/20.500.12854/50269
(EXLCZ)993710000000586922
carrierType_str_mv cr
is_hierarchy_title Innate immunity and neurodegenerative disorders /
author2_original_writing_str_mv noLinkedField
noLinkedField
_version_ 1796652211804045313
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04521nam a2200457 i 4500</leader><controlfield tag="001">993547286904498</controlfield><controlfield tag="005">20230621140712.0</controlfield><controlfield tag="006">m o u </controlfield><controlfield tag="007">cr#|||||||||||</controlfield><controlfield tag="008">160713s2014 sz a ob 010|0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9782889193103 (ebook)</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)3710000000586922</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(WaSeSS)IndRDA00059024</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/50269</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)993710000000586922</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">WaSeSS</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">WaSeSS</subfield><subfield code="d">UkMaJRU</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">QR185.2</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Francesca Cicchetti</subfield><subfield code="4">auth</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Innate immunity and neurodegenerative disorders /</subfield><subfield code="c">topic editors, Roger A. Barker and Francesca Cicchetti.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">Frontiers Media SA</subfield><subfield code="c">2014</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">[Lausanne, Switzerland] :</subfield><subfield code="b">Frontiers Media SA,</subfield><subfield code="c">2014.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (87 pages) :</subfield><subfield code="b">illustrations; digital, PDF file(s).</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="347" ind1=" " ind2=" "><subfield code="a">text file</subfield><subfield code="2">rda</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Frontiers Research Topics</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Inflammation of the brain in the context of neurodegenerative disorders is an area of intense debate and discussion, not least in terms of its pathogenic significance and the extent to which it drives disease processes and pathology. This inflammation can take several forms including innate responses involving microglia, humoral responses involving antibody, complement mediated processes and cellular T-cell activation, of which the role and extent of each may differ between diseases. Whilst some diseases have been more intensely linked to inflammation and long-term degeneration (e.g. MS), more traditional chronic neurodegenerative disorders have been thought of in terms of intrinsic neuronal pathology with a secondary innate response. However, it has been described that microglia activation is an early event of many degenerative disorders and evidence is accumulating that it may play a critical role in actually causing pathology and driving disease processes. If true, this would have major therapeutic implications, but what is the evidence that this is the case?The initial observations by Patrick McGeer’s group of post-mortem tissue from patients with Parkinson’s disease revealed the presence of activated brain microglia long-term and has thus lead to the hypothesis that chronic inflammation could participate to neuronal degenerative processes. The significance of these original observations has only been recently revisited, and the development of more powerful tools to study the brain immune response has certainly contributed to this field of research. Chronic inflammation in the brain can take many forms but of particular interest has been the resident microglia and the role they play in this process. In this context, microglia have often been thought to become activated only after the disease has begun and then to contribute minimally to the degenerative process. Emerging new concepts challenge this view by proposing that microglial senescence, for example, may release the disease process and/or accelerate it. In addition, microglia, once activated, can adopt different phenotypes which can be both pro-inflammatory and pro-repair and may impact not only on the healthy adult neuronal population but on those new neurons derived from neurogenic niches of the adult brain.In this Research Topic, we attempt to explore this by first considering the innate immune responses in the brain and the methods by which they can be studied experimentally and in patients with various neurodegenerative disorders. This sets the scene for then discussing a range of different disorders including Alzheimer’s, Parkinson’s, Huntington’s disease and amyotrophic lateral sclerosis. These papers seek to discuss the evidence for an innate immune response and whether this is beneficial or detrimental, as well as its therapeutic implications.</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on: online resource; title from pdf title page (frontiers, viewed Jul. 13, 2016).</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Natural immunity.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Nervous system</subfield><subfield code="x">Degeneration.</subfield></datafield><datafield tag="655" ind1=" " ind2="4"><subfield code="b">Elelctronic books.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Therapeutics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Inflammation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Immunity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Neurodegenerative disorders</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Animal Models</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Barker, Roger A.,</subfield><subfield code="d">1961-</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cicchetti, Francesca,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-06-25 13:35:00 Europe/Vienna</subfield><subfield code="d">00</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2016-02-13 18:39:49 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5338458630004498&amp;Force_direct=true</subfield><subfield code="Z">5338458630004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338458630004498</subfield></datafield></record></collection>